The global GLP-1 Receptor Agonist Market is estimated to be valued at US$ 15 billion in 2023 and is expected to exhibit a CAGR of 17% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
The global GLP-1 Receptor Agonist Market is estimated to be valued at US$ 14319.85 Mn in 2023 and is expected to exhibit a CAGR of 17.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
GLP-1 receptor agonists (also known as incretin mimetics) are a class of drugs used to treat type 2 diabetes. They work by mimicking the effects …
The global GLP-1 Receptor Agonist Market is estimated to be valued at US$ 14,319.85 Mn in 2023 and is expected to exhibit a CAGR of …
by 
